Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Quality of Life × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 98 Carcinoma, Intraductal, Noninfiltrating 5 Neoplasms 4 Breast Carcinoma In Situ 4 Neoplasm Metastasis 3 Carcinoma, Ductal, Breast 3 Inflammatory Breast Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Breast Cancer Female 2 Sleep Wake Disorders 1 Quality of Life 1 Pulmonary Fibrosis 1 Prostatic Neoplasms 1 Primary Breast Cancer 1 Paget's Disease, Mammary 1 Obesity 1 Neoplasm Recurrence, Local 1 Liver Neoplasms 1 Infertility 1 Fatigue 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Breast Cancer Subjects 1 Bone Density 1 Advanced Metastatic Breast Cancer 1

Interventions

Tamoxifen 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00784680 2009-05-01

ATAC - Quality of Life Sub-Protocol

AstraZeneca

Phase 3 Completed

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡